28.66 USD
↗ 1.43 (5.25%)AT CLOSE (11:59 AM EDT)
Alumis Inc. Common Stock
ALMSNASDAQ • USD
28.69
↗ 0.02 (0.09%)
POST MARKET (AS OF 07:35 PM EDT)
Post Market
AS OF 07:35 PM EDT
28.69
↗ 0.02 (0.09%)
Market: CLOSED
Shares of Alumis Inc. Common Stock (ALMS) are trading at $28.65. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jul 17, 2026.
Open?$26.87
High?$28.97
Low?$26.58
Prev. Close?$27.23
Volume?1.0M
Avg. Volume?1.7M
VWAP?$28.35
Rel. Volume?0.58x
Bid / Ask
Bid?$21.61 × 100
Ask?$33.27 × 100
Spread?$11.66
Midpoint?$27.44
Valuation & Ratios
Market Cap?3.5B
Shares Out?123.4M
Float?74.5M
Float %?60.4%
P/E Ratio?N/A
P/B Ratio?6.12
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Themes
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?27
Short Sent.?40
Piotroski F-Score?0/9Weak
Altman Z-Score?16.47Safe
Confidence?49%Low
Short InterestHigh
Short % of Float?19.19%High
Short Interest?14.3M
Days to Cover?7.6
Free Float74.5M
Avg Daily Volume1.9M
Settlement Date2026-06-30
Financial Health
Current Ratio?7.51Strong
Quick Ratio?7.51Strong
Cash Ratio?0.90Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?6.12FAIR▾
Peers100
S&P30
P/S?413.19HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-7.6CHEAP▾
S&P97
EV/Sales?405.58HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-41.9%WEAK▾
S&P3
ROA?-35.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-377030000
Enterprise Value?$3.4B
Fundamentals ratios updated end of day